Clinical Trials Directory

Trials / Completed

CompletedNCT02985073

A Comparison Between Biological (Veritas®) vs Non Biological Mesh (TIGR®) in Immediate Breast Reconstruction

The Gothenburg TIGR/Veritas® Study - A Comparison Between Biological (Veritas®) vs Non Biological Mesh (TIGR®) in Immediate Breast Reconstruction

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Vastra Gotaland Region · Other Government
Sex
Female
Age
20 Years
Healthy volunteers
Not accepted

Summary

This study compares the outcome using a biological mesh (Veritas®) compared to a non biological mesh (TIGR®) in immediate breast reconstruction.

Detailed description

The scientific evidence using different types of mesh in breast reconstruction is low at present with very few randomized controlled studies. This study aims to compare a biological mesh (Veritas®) compared to a non biological mesh (TIGR®) in patients with hereditary increased risk of developing breast cancer operated with bilateral immediate breast reconstruction regarding implant loss rate,infections,total complication rate,aesthetic outcome, HQOL (health related quality of Life) and economics. The patients will be enrolled to the study and sign an informed consent. At the operating theater the patient is randomized either to be reconstructed with Veritas® in one breast and TIGR® in the other breast.. The patients will be followed up according to a specified schedule until one year postoperatively as above.

Conditions

Interventions

TypeNameDescription
DEVICEVeritas®Biologic mesh
DEVICETIGR®Non biologic mesh

Timeline

Start date
2016-11-01
Primary completion
2020-01-01
Completion
2022-09-01
First posted
2016-12-07
Last updated
2022-10-17

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT02985073. Inclusion in this directory is not an endorsement.